NOX3 and sensorineural hearing loss disorder: After Oishi et al. successfully down-regulated Nox3 expression in the cochlea via direct injection into the murine inner ear [1144], Nacher-Soler and colleagues targeted Nox3 via siRNA in vivo as therapeutical option against sensorineural hearing loss [716].